Stock listing
Plus Therapeutics, Inc.
Selected listing: XMP1 · MUN · EUR · DE
Plus Therapeutics, Inc. (Munich:XMP1), Health Technology. Latest release Jul 31, 2026: Cerenome Launches as an Integrated CNS Oncology Company.
- Ticker
- Munich:XMP1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Munich
- Currency
- EUR
Latest news from Plus Therapeutics, Inc.
Cerenome Launches as an Integrated CNS Oncology Company
July 31, 2026
Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
July 28, 2026
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
July 21, 2026
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
July 16, 2026
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
July 14, 2026
Events
Research Plus Therapeutics, Inc.
Plus Therapeutics, Inc. company profile
View the public company page for Plus Therapeutics, Inc. on 6ix.
Plus Therapeutics, Inc. news
Read company news and market updates connected to Plus Therapeutics, Inc..
Plus Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Plus Therapeutics, Inc..
Alternate listings
PSTV:NASDAQ
US · USD
Alternate listing for Plus Therapeutics, Inc.; the primary context on this page is XMP1:MUN.
PSTV:BOATS
US · USD
Alternate listing for Plus Therapeutics, Inc.; the primary context on this page is XMP1:MUN.
XMP1:FWB
DE · EUR
Alternate listing for Plus Therapeutics, Inc.; the primary context on this page is XMP1:MUN.
XMP1:GETTEX
DE · EUR
Alternate listing for Plus Therapeutics, Inc.; the primary context on this page is XMP1:MUN.
XMP1:DUS
DE · EUR
Alternate listing for Plus Therapeutics, Inc.; the primary context on this page is XMP1:MUN.